Article info

Download PDFPDF

Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis
Free
  1. Correspondence to:
    Dr M C Hochberg, 10 S Pine St, MSTF 8-34, Baltimore, MD 21201 USA;
    mhochber{at}umaryland.edu
View Full Text

Citation

Hochberg MC, Tracy JK, Hawkins-Holt M, et al
Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis

Publication history

  • First published October 7, 2003.
Online issue publication 
October 07, 2003

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.